Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

ELLIS W LADER

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1538151782
CMS profile
251476
Location
KINGSTON, NY

General Payments · PY2018–2024

$6,158.20

  • Reported across 178 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$488.77

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $488.77 16

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $1,140.24 56
PY2019 $687.66 25
PY2020 $92.73 4
PY2021 $535.56 16
PY2022 $1,070.94 36
PY2023 $2,142.30 25
PY2024 $488.77 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $20.83 04/10/2024 Food and Beverage Undisputed 01/23/2026 1111626771 CMS
AstraZeneca Pharmaceuticals LP $16.90 04/06/2024 Food and Beverage Undisputed 01/23/2026 1105789364 CMS
E.R. Squibb & Sons, L.L.C. $16.95 03/08/2024 Food and Beverage Undisputed 01/23/2026 1101808384 CMS
E.R. Squibb & Sons, L.L.C. $14.95 05/10/2024 Food and Beverage Undisputed 01/23/2026 1101808446 CMS
E.R. Squibb & Sons, L.L.C. $100.46 05/29/2024 Food and Beverage Undisputed 01/23/2026 1101808435 CMS
E.R. Squibb & Sons, L.L.C. $1.87 06/26/2024 Food and Beverage Undisputed 01/23/2026 1101808457 CMS
E.R. Squibb & Sons, L.L.C. $11.36 06/26/2024 Food and Beverage Undisputed 01/23/2026 1101808461 CMS
Kiniksa Pharmaceuticals International, plc $22.88 01/12/2024 Food and Beverage Undisputed 01/23/2026 1154872433 CMS
Kiniksa Pharmaceuticals International, plc $26.21 02/07/2024 Food and Beverage Undisputed 01/23/2026 1154872443 CMS
Lilly USA, LLC $55.32 01/29/2024 Food and Beverage Undisputed 01/23/2026 1136165966 CMS
Lilly USA, LLC $83.32 03/25/2024 Food and Beverage Undisputed 01/23/2026 1136161595 CMS
MEDICOMP INC $44.53 02/26/2024 Food and Beverage Undisputed 01/23/2026 1067448908 CMS
Merck Sharp & Dohme LLC $13.55 05/03/2024 Food and Beverage Undisputed 01/23/2026 1141679163 CMS
Novartis Pharmaceuticals Corporation $14.82 01/03/2024 Food and Beverage Undisputed 01/23/2026 1087063186 CMS
Novartis Pharmaceuticals Corporation $18.85 03/15/2024 Food and Beverage Undisputed 01/23/2026 1087063182 CMS
Novartis Pharmaceuticals Corporation $25.97 07/24/2024 Food and Beverage Undisputed 01/23/2026 1087063208 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.